Meetings in Brief: FDA Blood Products Advisory Committee
This article was originally published in The Gray Sheet
Executive Summary
FDA Blood Products Advisory Committee: will convene Dec. 14-15 in Rockville, Maryland. During the morning of Dec. 14, the committee will hear agency updates on HIV-1 antigen screening and scientific presentations on testing for Chagas disease (infection with Trypanosoma cruzi) in blood donors. On Dec. 15, the committee will review issues related to site visit reports of the Laboratories of Molecular Virology and Immunochemistry, Division of Transmitted Diseases...